Printer Friendly

The bottom line: data from recent industry financial reports. Dollar amounts in millions.

The Bottom Line
Data from recent industry financial reports. Dollar amounts in
millions.

Company                    Period  Ended     Sales     Chg.   Op. Prof.

Caliper Technologies        1Q     31-Mar     $7.0   -28.1%   ($11.7)
Celera Genomics             1Q     31-Mar    $30.5    30.3%   ($61.8)
Emerson (Process Control)   2Q     31-Mar   $836.5    -1.6%      N/A
Harvard Bioscience          1Q     31-Mar    $12.0    39.0%     $1.8
Invision Technologies       1Q     31-Mar    $33.2    89.7%     $4.7
Isco                        3Q     26-Mar    $14.1     2.6%     $0.2
Kewaunee Scientific         4Q     30-Mar    $21.8    16.9%     $0.8
Kewaunee Scientific         FYE    30-Mar    $84.8    10.1%     $2.9
Luminex                     1Q     30-Mar     $2.3   -40.8%    ($6.7)
O.I. Corp.                  1Q     31-Mar     $5.1   -23.2%    ($0.3)
Osmonics                    1Q     31-Mar    $53.2    -0.2%     $4.1
Perbio Science AB           1Q     31-Mar    $52.8    20.4%     $9.5
Pharmacopeia                1Q     31-Mar    $26.8     5.0%    ($7.2)
Pyrosequencing AB           1Q     31-Mar     $1.9     2.0%    ($3.3)
Roper Industries            1Q     31-Mar   $149.6     8.7%   ($24.6)
Sepracor                    1Q     31-Mar    $46.8    64.4%   ($60.0)
Strategic Diagnostics       1Q     31-Mar     $5.6   -19.2%    ($0.9)
X-Rite                      1Q     31-Mar    $21.0   -17.4%    ($0.3)

Company                       Chg.     Net Prof.      Chg.

Caliper Technologies             NM      ($9.7)         NM
Celera Genomics                  NM     ($49.5)         NM
Emerson (Process Control)       N/A      $94.9        16.9%
Harvard Bioscience            23.8%       $1.2         5.8%
Invision Technologies       4282.4%       $2.8      3066.3%
Isco                         -28.7%       $0.3        27.9%
Kewaunee Scientific           32.1%       $0.6        15.4%
Kewaunee Scientific           23.1%       $1.9        48.8%
Luminex                          NM      ($6.4)         NM
O.I. Corp.                       NM      ($0.2)         NM
Osmonics                      -7.9%       $2.6        -3.0%
Perbio Science AB             25.8%       $5.5        19.5%
Pharmacopeia                     NM      ($6.0)         NM
Pyrosequencing AB                NM      ($3.1)         NM
Roper Industries              12.7%      $14.5        23.4%
Sepracor                         NM    ($114.8)         NM
Strategic Diagnostics            NM      ($0.4)         NM
X-Rite                           NM      ($0.3)         NM

NA--not availab]e NM=not meaningful
COPYRIGHT 2002 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Instrument Business Outlook
Article Type:Brief Article
Geographic Code:1USA
Date:Jun 15, 2002
Words:331
Previous Article:Market profile: Headspace.
Next Article:NMR: the competitive challenges increase.
Topics:


Related Articles
The Bottom Line.
The bottom line: data from the recent industry financial reports. Dollar amounts in millions.
The bottom line.
The bottom line.
The bottom line: data from recent industry financial reports. Dollar amounts in million.
The bottom line.
The bottom line.
The bottom line.
The bottom line.
The bottom line: data from recent industry financial reports. Dollar amounts in millions.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters